Earnings roundup: Yahoo, CSX |
|
|
|
Published
:
Tue, 16 Oct 2007 23:07 |
(AP) - Among the earnings stories for Tuesday, Oct. 16, from AP Financial News:Top stories:SAN FRANCISCO (AP) -- Yahoo Inc.'s third-quarter profit slipped less than analysts feared, raising hopes that the slumping Internet powerhouse can deliver on the comeback promises of a new management team that took over four months ago.JACKSONVILLE, Fla. (AP) -- Railroad operator CSX Corp. said Tuesday its third-quarter profit rose 24 percent as increased revenue per unit helped counter declines in freight volume.Other stories:BOSTON (AP) -- Strength in services overcame a slide in hardware and helped third-quarter earnings rise 6 percent at International Business Machines Corp., enough to beat Wall Street expectations Tuesday.AUBURN HILLS, Mich. (AP) -- Modular home builder Champion Enterprises Inc. said Tuesday its third quarter profit climbed 43 percent on strong sales in the company's international division which offset lackluster U.S. results.NEW YORK (AP) -- EXFO Electro-Optical Engineering Inc., which makes test and measuring products for telecommunications companies, said Tuesday fiscal fourth-quarter earnings rose sharply, helped by one-time benefits.SAN FRANCISCO (AP) -- Genentech Inc. barely beat Wall Street estimates for the third quarter, and many analysts are skeptical that world's second-largest biotech company can maintain its scorching momentum amid new competition and a saturated market.CHASKA, Minn. (AP) -- Medical materials and device maker Lifecore Biomedical Inc. said Tuesday profit rose 11 percent in its fiscal first quarter, as the weaker dollar and demand for its Prima dental implant system helped drive sales up 5 percent.ATLANTA (AP) -- The chief executive of Delta Air Lines Inc. said Tuesday that the carrier wants to be the 'undisputed leader' in the industry and that a deal with another airline may be in its best interest.TRENTON, N.J. (AP) -- Health care products maker Johnson & Johnson said Tuesday its third-quarter profit fell about 8 percent because of a charge for cutting jobs and lower sales of top sellers, including stents and a key drug hurt by safety questions.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|